Senate bill · S. 3716 (119th Congress)
RARE Act
U.S. Senate
Sponsor: Tammy Baldwin (U.S. Senator for Wisconsin, Democratic)
Following needs an Agora account. You will sign in first, then come back to this page.
From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data
Summary
Would narrow the seven-year market exclusivity granted to drugs approved for rare diseases so that it applies only to the specific approved use or indication, rather than to the rare disease or condition as a whole.
AI summary. Not an official summary. How we handle summaries
Where it stands
Assigned to a committee for review.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
Senate Committee on Health, Education, Labor, and Pensions · U.S. Senate
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Related bills
- H.R. 1262Mikaela Naylon Give Kids a Chance ActRelated bill
- S. 891Bipartisan Health Care ActRelated bill
As identified by Congress.gov.
Full history
- Jan 28, 2026
Introduced
Introduced in U.S. Senate
U.S. Senate
- Jan 28, 2026
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jan 28, 2026
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jan 28, 2026
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Read the record
- Read on Congress.gov (opens in a new tab) The official record on Congress.gov.